Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 5/20 | 0.50 |
| ▸ | MAPT | P10636 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | GFER | P55789 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.42 |
| ▸ | RELA | Q04206 | 1/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.42 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.42 |
| ▸ | DAO | P14920 | 1/20 | 0.40 |
| ▸ | CASP3 | P42574 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11997754 | 1.00 | NPC1 (0.50) | NPC1MAPTALDH1A1HSD17B10GFER | |
| SCHEMBL12170048 | 1.00 | NPC1 (0.50) | NPC1MAPTALDH1A1HSD17B10GFER | |
| SCHEMBL12982405 | 1.00 | NPC1 (0.50) | NPC1MAPTALDH1A1HSD17B10GFER | |
| SCHEMBL12982161 | 1.00 | NPC1 (0.50) | NPC1MAPTALDH1A1HSD17B10GFER | |
| SCHEMBL29764 | 0.97 | NPC1 (0.52) | NPC1MAPTALDH1A1HSD17B10GFER | |
| SCHEMBL13376691 | 0.89 | APP (0.50) | NPC1MAPTALDH1A1HSD17B10GFER | |
| SCHEMBL12887840 | 0.87 | CYP3A4 (0.46) | NPC1MAPTALDH1A1HSD17B10GFER | |
| SCHEMBL12982748 | 0.84 | NPC1 (0.41) | NPC1MAPTALDH1A1HSD17B10GFER | |
| SCHEMBL8508163 | 0.84 | MAPT (0.42) | NPC1MAPTALDH1A1HSD17B10GFER | |
| SCHEMBL13407308 | 0.84 | NPC1 (0.41) | NPC1MAPTALDH1A1HSD17B10GFER |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 313 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220416167-A1 | OSMIUM-CONTAINING CONJUGATED POLYMER AND METHODS THEREOF | XIAMEN UNIVERSITY (CN) | 2022-12-29 | — | — | US | disclosed |
| US-11203688-B2 | Composite containing organic/metallic hybrid polymer and ionic liquid, electrochromic device in which same is used, and method for manufacturing said composite and device | NATIONAL INSTITUTE FOR MATERIALS SCIENCE (JP) | 2021-12-21 | — | — | US | disclosed |
| US-20210317260-A1 | POLYMER, COMPOSITION, ELECTROCHROMIC ELEMENT, DIMMING DEVICE, AND DISPLAY DEVICE | NATIONAL INSTITUTE FOR MATERIALS SCIENCE (JP) | 2021-10-14 | — | — | US | disclosed |
| WO-2021143690-A1 | OSMIUM-CONTAINING CONJUGATED POLYMER, PREPARATION METHOD THEREFOR AND USE THEREOF | 厦门大学 | 2021-07-22 | — | — | WO | disclosed |
| US-20210141279-A1 | ELECTROCHROMIC DEVICE USING ORGANIC/METAL HYBRID POLYMER AND METHOD FOR PRODUCING SAME | NATIONAL INSTITUTE FOR MATERIALS SCIENCE (JP) | 2021-05-13 | — | — | US | disclosed |
| US-20210139643-A1 | POLYMER COMPOUND AND ORGANIC PHOTOELECTRIC CONVERSION ELEMENT USING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-05-13 | — | — | US | disclosed |
| EP-2379109-B1 | COMBINATION OF PHOTODYNAMIC THERAPY AND ANTI-VEGF AGENTS IN THE TREATMENT OF UNWANTED CHOROIDAL NEOVASCULATURE | BAUSCH HEALTH COMPANIES INC (CA) | 2020-10-07 | — | — | EP | disclosed |
| EP-3674791-A1 | ELECTROCHROMIC ELEMENT AND DISPLAY SYSTEM USING SAME | National Institute for Materials Science (JP) | 2020-07-01 | — | — | EP | disclosed |
| US-20200192171-A1 | ELECTROCHROMIC ELEMENT AND DISPLAY SYSTEM USING SAME | NATIONAL INSTITUTE FOR MATERIALS SCIENCE (JP) | 2020-06-18 | — | — | US | disclosed |
| US-10636975-B2 | Organic semiconductor element, compound, organic semiconductor composition, and method of manufacturing organic semiconductor film | FUJIFILM CORPORATION (JP) | 2020-04-28 | — | — | US | disclosed |
| WO-2002062386-A2 | PHOTODYNAMIC THERAPY OF OCCULT CHOROIDAL NEOVASCULARIZATION LINKED TO AGE-RELATED MACULAR DEGENERATION | QLT INC. (CA) | 2002-08-15 | — | — | WO | disclosed |
| WO-2002062384-A2 | REDUCED FLUENCE RATE PDT | QLT INC. (CA) | 2002-08-15 | — | — | WO | disclosed |
| EP-1229937-A2 | USE OF PDT TO INHIBIT INTIMAL HYPERPLASIA | QLT Inc. (CA) | 2002-08-14 | — | — | EP | disclosed |
| US-20020061330-A1 | Supports for photosensitizer formulations | BRITISH COLUMBIA, THE UNIVERSITY OF (CA) | 2002-05-23 | — | — | US | disclosed |
| US-6355365-B1 | FOR USE IN ORGANIC ELECTRO LUMINESCENCE (EL) DEVICE; EFFICIENCY | JAPAN CHEMICAL INNOVATION INSTITUTE (JP) | 2002-03-12 | — | — | US | disclosed |
| US-20020022032-A1 | Immuno-adjuvant PDT treatment of metastatic tumors | QLT INC. (CA) | 2002-02-21 | — | — | US | disclosed |
| WO-2001085212-A2 | DRUG DELIVERY SYSTEMS FOR PHOTODYNAMIC THERAPY | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2001-11-15 | — | — | WO | disclosed |
| WO-2001035996-A2 | USE OF PDT TO INHIBIT INTIMAL HYPERPLASIA | QLT INC. (CA) | 2001-05-25 | — | — | WO | disclosed |
| WO-2001035997-A2 | USE OF LOW-DOSE PDT TO INHIBIT RESTENOSIS | QLT INC. (CA) | 2001-05-25 | — | — | WO | disclosed |
| US-5045563-A | Terthienyl Compound | HER MAJESTY THE QUEEN IN RIGHT OF CANADA, AS REPRESENTED BY MINISTER OF NATIONAL DEFENCE OF HER MAJESTY'S CANADIAN GOVERNMENT (CA) | 1991-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020061330-A1 | Supports for photosensitizer formulations | PPOX, PPIF, SDHA | NPC1 1133/4885MAPT 1710/4885ALDH1A1 371/4885 |
| US-20020022032-A1 | Immuno-adjuvant PDT treatment of metastatic tumors | CD74, ANXA11, ANXA1 | NPC1 2358/4885MAPT 1243/4885ALDH1A1 794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.